We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 10 januari 2018

British Journal of Cancer - Table of Contents alert Volume 118 Issue 1

If you are unable to see the message below, click here to view.
British Journal of Cancer

Volume 118, Issue 1 (January 2018)

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed


Cell and molecular biology: a new section joins the fight against cancer

Colin R Goding

British Journal of Cancer 2017 118: 1 - 2; December 12, 2017; 10.1038/bjc.2017.443


Abstract | Full Text


Targeting the Raf kinases in human cancer: the Raf dimer dilemma

David E Durrant & Deborah K Morrison

British Journal of Cancer 2017 118: 3 - 8; December 14, 2017; 10.1038/bjc.2017.399


Abstract | Full Text


Mechanisms of resistance to immune checkpoint inhibitors

Russell W Jenkins, David A Barbie& Keith T Flaherty

British Journal of Cancer 2018 118: 9 - 16; January 02, 2018; 10.1038/bjc.2017.434


Abstract | Full Text

Clinical Studies

Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity

S M Reddy, C H Barcenas, A K Sinha, L Hsu, S L Moulder et al.

British Journal of Cancer 2017 118: 17 - 23; December 12, 2017; 10.1038/bjc.2017.379


Abstract | Full Text

Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670?000 patients with cancers of 35 different sites

Y Zhou, S C Mendonca, G A Abel, W Hamilton, F M Walter et al.

British Journal of Cancer 2017 118: 24 - 31; November 28, 2017; 10.1038/bjc.2017.381


Abstract | Full Text

Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

Shigeki Nanjo, Akito Hata, Chiyuki Okuda, Reiko Kaji, Hideaki Okada et al.

British Journal of Cancer 2017 118: 32 - 37; November 30, 2017; 10.1038/bjc.2017.394


Abstract | Full Text

Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC

Shirish Gadgeel, Alice T Shaw, Fabrice Barlesi, Lucio Crinò, James Chih-Hsin Yang et al.

British Journal of Cancer 2017 118: 38 - 42; November 16, 2017; 10.1038/bjc.2017.395


Abstract | Full Text

Translational Therapeutics

Targeting de novo lipogenesis as a novel approach in anti-cancer therapy

Katharina Stoiber, Olga Naglo, Carla Pernpeintner, Siwei Zhang, Andreas Koeberle et al.

British Journal of Cancer 2017 118: 43 - 51; November 07, 2017; 10.1038/bjc.2017.374


Abstract | Full Text

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors

Jaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, Arlene M Correa, Lang Ma et al.

British Journal of Cancer 2017 118: 52 - 61; November 14, 2017; 10.1038/bjc.2017.388


Abstract | Full Text

Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response

Mu-qing Yang, Qiang Du, Patrick R Varley, Julie Goswami, Zhihai Liang et al.

British Journal of Cancer 2017 118: 62 - 71; November 07, 2017; 10.1038/bjc.2017.389


Abstract | Full Text

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer

Stephanie Markovina, Songyan Wang, Lauren E Henke, Cliff J Luke, Stephen C Pak et al.

British Journal of Cancer 2017 118: 72 - 78; November 07, 2017; 10.1038/bjc.2017.390


Abstract | Full Text

Molecular Diagnostics

Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library

Lidan Hou, Danxi Zhu, Yu Liang, Xiaohui Tian, Lei Li et al.

British Journal of Cancer 2017 118: 79 - 87; October 24, 2017; 10.1038/bjc.2017.366


Abstract | Full Text

Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-ß-induced epithelial mesenchymal transition through controlling Twist1 expression

Jieping Hu, Jing Tian, Shimiao Zhu, Libin Sun, Jianpeng Yu et al.

British Journal of Cancer 2017 118: 88 - 97; November 09, 2017; 10.1038/bjc.2017.372


Abstract | Full Text

Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma


British Journal of Cancer 2017 118: 98 - 105; November 09, 2017; 10.1038/bjc.2017.384


Abstract | Full Text

Genetics & Genomics

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

Higinio Dopeso, Paulo Rodrigues, Josipa Bilic, Sarah Bazzocco, Fernando Cartón-García et al.

British Journal of Cancer 2017 118: 106 - 116; December 05, 2017; 10.1038/bjc.2017.420


Abstract | Full Text


Maternal diabetes and risk of childhood acute lymphoblastic leukaemia in the offspring


British Journal of Cancer 2017 118: 117 - 120; October 03, 2017; 10.1038/bjc.2017.351


Abstract | Full Text

Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology Group

Jenny N Poynter, Michaela Richardson, Michelle Roesler, Mark Krailo, James F Amatruda et al.

British Journal of Cancer 2017 118: 121 - 126; October 24, 2017; 10.1038/bjc.2017.358


Abstract | Full Text

A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia

Jeremiah Hwee, Christopher Tait, Lillian Sung, Jeffrey C Kwong, Rinku Sutradhar et al.

British Journal of Cancer 2017 118: 127 - 137; October 24, 2017; 10.1038/bjc.2017.360


Abstract | Full Text

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

J U H Lam, K M Elfström, D M Ejegod, H Pedersen, C Rygaard et al.

British Journal of Cancer 2017 118: 138 - 144; November 14, 2017; 10.1038/bjc.2017.371


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.